LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

LaunchPad Medical, Inc. announced that it has successfully enrolled half of the twenty patents approved by the FDA for its two-site pilot clinical study. This study constitutes the first clinical use of Tetranite®, a bone adhesive biomaterial. Read more >>